Teva Pharmaceutical Industries Ltd (NYSE:TEVA)
| 8.86 Delayed Data As of 4:11pm ET |  -0.31 / -3.38%Today’s Change | 7.73 Today|||52-Week Range 13.30 | +10.61% Year-to-Date |
Latest TEVA News | Press Releases
| Does Teva Pharmaceutical Deserve a Place in Your 2022 Portfolio? Jan 12 / StockNews.com - Paid Partner Content |
Today’s Trading
| Previous close | 9.17 |
| Today’s open | 9.08 |
| Day’s range | 8.84 - 9.12 |
| Volume | 8,963,843 |
| Average volume (3 months) | 9,580,889 |
| Market cap | $10.1B |
Data as of 4:11pm ET, 01/18/2022
Growth & Valuation
| Earnings growth (last year) | -297.93% |
| Earnings growth (this year) | -0.91% |
| Earnings growth (next 5 years) | +2.30% |
| Revenue growth (last year) | -1.27% |
| P/E ratio | 13.5 |
| Price/Sales | 0.63 |
| Price/Book | 1.00 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| BBIOBridgeBio Pharma Inc | -0.97 | -7.61% |
| ---- | ||
| IMMBImmunotech Laborator... | 0.00 | 0.00% |
| BGNEBeigene Ltd | +1.01 | +0.42% |
Data as of 4:01pm ET, 01/18/2022
Financials
| Next reporting date | February 10, 2022 |
| EPS forecast (this quarter) | $0.73 |
| Annual revenue (last year) | $16.7B |
| Annual profit (last year) | -$4.0B |
| Net profit margin | -23.95% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Generic |
No executives to display |
Corporate headquarters Petach Tikva, Hamerkaz |
Forecasts
